Abstract
Short sleep is held to cause poorer brain health, but is short sleep associated with higher rates of brain structural decline? Analysing 8,153 longitudinal MRIs from 3,893 healthy adults, we found no evidence for an association between sleep duration and brain atrophy. In contrast, cross-sectional analyses (51,295 observations) showed inverse U-shaped relationships, where a duration of 6.5 (95% confidence interval, (5.7, 7.3)) hours was associated with the thickest cortex and largest volumes relative to intracranial volume. This fits converging evidence from research on mortality, health and cognition that points to roughly seven hours being associated with good health. Genome-wide association analyses suggested that genes associated with longer sleep for below-average sleepers were linked to shorter sleep for above-average sleepers. Mendelian randomization did not yield evidence for causal impacts of sleep on brain structure. The combined results challenge the notion that habitual short sleep causes brain atrophy, suggesting that normal brains promote adequate sleep duration—which is shorter than current recommendations.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Nature Human Behaviour |
| Jahrgang | 7 |
| Ausgabenummer | 11 |
| Seiten (von - bis) | 2008-2022 |
| Seitenumfang | 15 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 11.2023 |
Fördermittel
The Lifebrain consortium is funded by the EU Horizon 2020 grant agreement no. 732592 (Lifebrain). The different sub-studies are supported by different sources. LCBC is supported by the European Research Council under grant agreements no. 283634 and no. 725025 (to A.M.F.) and no. 313440 (to K.B.W.), as well as the Norwegian Research Council (to A.M.F. and K.B.W.) and the National Association for Public Health’s dementia research programme, Norway (to A.M.F.). Betula is supported by a scholar grant from the Knut and Alice Wallenberg foundation to L.N. Barcelona is partially supported by a Spanish Ministry of Economy and Competitiveness grant to D.B.-F. (grant no. PSI2015-64227-R (AEI/FEDER, UE)); by the Walnuts and Healthy Aging study ( http://www.clinicaltrials.gov ; grant no. NCT01634841) funded by the California Walnut Commission, Sacramento, California; and by an ICREA Academia 2019 award. BASE-II has been supported by the German Federal Ministry of Education and Research under grant nos 16SV5537, 16SV5837, 16SV5538, 16SV5536K, 01UW0808, 01UW0706, 01GL1716A and 01GL1716B and by the European Research Council under grant agreement no. 677804 (to S.K.). Work on the Whitehall II Imaging Substudy was mainly funded by Lifelong Health and Well-being Programme grant no. G1001354 from the UK Medical Research Council (‘Predicting MRI Abnormalities with Longitudinal Data of the Whitehall II Substudy’) to K.P.E. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from award no. 203139/Z/16/Z from the Wellcome Trust. The data were provided (in part) by the Human Connectome Project, WU-Minn Consortium (principal investigators: D. Van Essen and K. Ugurbil; 1U54MH091657), funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. Part of the research was conducted using the UKB resource under application no. 32048. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
| Träger | Trägernummer |
|---|---|
| California Walnut Commission | |
| Knut och Alice Wallenbergs Stiftelse | |
| Norges Idrettshøgskole | |
| National Association for Public Health | |
| Norges Forskningsråd | |
| Agencia Estatal de Investigación | |
| Horizon 2020 | |
| WU-Minn Consortium | 1U54MH091657 |
| Bundesministerium für Bildung und Forschung | 677804, 16SV5536K, 01GL1716B, 01GL1716A, 01UW0808, 01UW0706, 16SV5538, 16SV5537, 16SV5837 |
| Horizon 2020 Framework Programme | 732592 |
| McDonnell Center for Systems Neuroscience | 32048 |
| European Regional Development Fund | NCT01634841 |
| Wellcome Trust | 203139 |
| Ministerio de Economía y Competitividad | PSI2015-64227-R |
| European Research Council | 283634, 725025, 313440 |
| Lifelong Health and Well-being Programme | G1001354 |
| Medical Research Council | 203139/Z/16/Z |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)
- Querschnittsbereich: Medizinische Genetik
DFG-Fachsystematik
- 2.23-06 Molekulare und zelluläre Neurologie und Neuropathologie
KDSF-Klassifikation für Forschungsfelder
- 231 - Zellen und Gene
Fingerprint
Untersuchen Sie die Forschungsthemen von „No phenotypic or genotypic evidence for a link between sleep duration and brain atrophy“. Zusammen bilden sie einen einzigartigen Fingerprint.Projekte
- 2 Abgeschlossen
-
Entwicklung und Validierung von DNA-Methylation-Clocks unter Nutzung von Verlaufsdaten der Berliner Altersstudie II (BASE-II)
Bertram, L. (Projektleiter*in (PI)) & Demuth, I. (Projektleiter*in (PI))
01.01.21 → 31.12.25
Projekt: DFG Einzelprojekte › DFG Einzelförderungen (Sachbeihilfen)
Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver